These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23494835)

  • 1. Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation.
    Patel DD; Anderson BD
    J Pharm Sci; 2013 May; 102(5):1544-53. PubMed ID: 23494835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
    Patel DD; Joguparthi V; Wang Z; Anderson BD
    J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of precipitation inhibitors on indomethacin supersaturation maintenance: mechanisms and modeling.
    Patel DD; Anderson BD
    Mol Pharm; 2014 May; 11(5):1489-99. PubMed ID: 24654924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of Polyvinylpyrrolidone and its Impact on Maintenance of Aqueous Supersaturation of Indomethacin via Crystal Growth Inhibition.
    Patel DD; Anderson BD
    J Pharm Sci; 2015 Sep; 104(9):2923-33. PubMed ID: 26037309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of Polymeric Additives on Nucleation and Crystal Growth of Indomethacin from Supersaturated Solutions.
    Cheng H; Mao L; Zhang S; Lv H
    AAPS PharmSciTech; 2019 May; 20(5):193. PubMed ID: 31115746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the Slowing of Desupersaturation of a Weak Acid at Elevated pH.
    Manchanda A; Li N; Bogner RH
    Mol Pharm; 2020 Oct; 17(10):3759-3772. PubMed ID: 32790317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of alginate-drug miscibility on its crystal growth inhibition effect in supersaturated drug delivery system.
    Guan J; Liu Q; Liu J; Cui Z; Zhang X; Mao S
    Carbohydr Polym; 2020 Feb; 230():115601. PubMed ID: 31887891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.
    Sun DD; Lee PI
    Mol Pharm; 2013 Nov; 10(11):4330-46. PubMed ID: 24066837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently?
    Ferretti V; Dalpiaz A; Bertolasi V; Ferraro L; Beggiato S; Spizzo F; Spisni E; Pavan B
    Mol Pharm; 2015 May; 12(5):1501-11. PubMed ID: 25794305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of formation and dissolution of uric acid crystals.
    Lam CY; Nancollas GH; Ko SJ
    Invest Urol; 1978 May; 15(6):473-7. PubMed ID: 649297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous nucleation and growth of calcium carbonate on calcite and quartz.
    Lioliou MG; Paraskeva CA; Koutsoukos PG; Payatakes AC
    J Colloid Interface Sci; 2007 Apr; 308(2):421-8. PubMed ID: 17258223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-scattering investigations of nucleation processes and kinetics of crystallization in macromolecular systems.
    Malkin AJ; McPherson A
    Acta Crystallogr D Biol Crystallogr; 1994 Jul; 50(Pt 4):385-95. PubMed ID: 15299390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.